Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Transgene S.A. (Euronext: TNG)

Transgene is a France-based biopharmaceutical company focused on the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. The Company has four compounds in Phase II clinical trials: TG4010, JX594/TG6006, TG4001/RG3484 and TG4040 and one compound in Phase I clinical trial: TG4023. Transgene has entered into strategic collaborative agreements for the development of two of its immunotherapy products: - An option agreement with Novartis for an exclusive license to develop TG4010 for the treatment of various cancers, including non small cell lung cancer (NSCLC) - An in-licensing agreement with US-based Jennerex Biotherapeutics, Inc., to develop and market JX594 (JX594/TG6006), an oncolytic product. Transgene has bio-manufacturing capacities for viral-based vectors. *

 

Period Start 1979-01-01 established
  Group Mérieux (Group)
Products Industry therapeutic vaccine
  Industry 2 immunotherapy
Person Person Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene)
     
Region Region Strasbourg
  Country France
  Street Boulevard Gonthier d’Andernach
Parc d’Innovation d’Illkirch
  City 67405 Illkirch
  Tel +33-3-8827-9100
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2006-12-31)
  Currency EUR
  Annual sales 28,019,000 (revenues, total (2007) 2007-12-31)
  Profit -5,521,000 (2007-12-31)
  Cash 84,100,000 (2014-09-30)
     
    * Document for �About Section�: 
     
   
Record changed: 2020-12-04

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top